Nanoparticle-Based Cancer Therapy: A Novel Approach

Abstract

Nanoparticle-mediated drug delivery has shown great potential for cancer treatment, offering improved delivery of anticancer agents, reduced systemic toxicity, and enhanced therapeutic efficacy. The Novel Drug delivery system's compact size yields significant benefits, including modified pharmacokinetic profiles and enhanced payload capacity, surpassing conventional large-scale systems. Although preclinical and clinical phases have yielded positive responses, further research is necessary to overcome challenges related to stability and potential side effects, ultimately enhancing therapeutic applications. To address stability concerns, experts are exploring techniques to stabilize nanoparticles, including protective coatings and formulation optimization. Furthermore, they are selecting biocompatible materials and conducting toxicological studies to mitigate potential side effects before proceeding to clinical trials. This review provides a comprehensive analysis of existing literature on nanoparticle-based drug delivery systems, focusing on their applications and efficacy in cancer treatment.